Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis

Leukostasis in acute and chronic leukemias leads to increased cell burden and increased blood viscosity. Therapeutic leukocytapheresis is an automated procedure aimed at white blood cell depletion, and it thereby reduces the complications associated with increased blood viscosity, such as thrombotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghuwanshi, Babita, Chouhan, Sunil, Jain, Anuj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845160/
https://www.ncbi.nlm.nih.gov/pubmed/33527056
http://dx.doi.org/10.7759/cureus.12375
_version_ 1783644499420905472
author Raghuwanshi, Babita
Chouhan, Sunil
Jain, Anuj
author_facet Raghuwanshi, Babita
Chouhan, Sunil
Jain, Anuj
author_sort Raghuwanshi, Babita
collection PubMed
description Leukostasis in acute and chronic leukemias leads to increased cell burden and increased blood viscosity. Therapeutic leukocytapheresis is an automated procedure aimed at white blood cell depletion, and it thereby reduces the complications associated with increased blood viscosity, such as thrombotic events and mortality. In this report, we present the case of a 25-year-old patient with leukostasis and splenic laceration who was treated with therapeutic leukocytapheresis with symptomatic relief in leukostasis.
format Online
Article
Text
id pubmed-7845160
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-78451602021-01-31 Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis Raghuwanshi, Babita Chouhan, Sunil Jain, Anuj Cureus Hematology Leukostasis in acute and chronic leukemias leads to increased cell burden and increased blood viscosity. Therapeutic leukocytapheresis is an automated procedure aimed at white blood cell depletion, and it thereby reduces the complications associated with increased blood viscosity, such as thrombotic events and mortality. In this report, we present the case of a 25-year-old patient with leukostasis and splenic laceration who was treated with therapeutic leukocytapheresis with symptomatic relief in leukostasis. Cureus 2020-12-30 /pmc/articles/PMC7845160/ /pubmed/33527056 http://dx.doi.org/10.7759/cureus.12375 Text en Copyright © 2020, Raghuwanshi et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Hematology
Raghuwanshi, Babita
Chouhan, Sunil
Jain, Anuj
Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
title Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
title_full Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
title_fullStr Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
title_full_unstemmed Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
title_short Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
title_sort leukocytapheresis in chronic myeloid leukemia with leukostasis
topic Hematology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845160/
https://www.ncbi.nlm.nih.gov/pubmed/33527056
http://dx.doi.org/10.7759/cureus.12375
work_keys_str_mv AT raghuwanshibabita leukocytapheresisinchronicmyeloidleukemiawithleukostasis
AT chouhansunil leukocytapheresisinchronicmyeloidleukemiawithleukostasis
AT jainanuj leukocytapheresisinchronicmyeloidleukemiawithleukostasis

Ejemplares similares